Team

We are a world-class team with a track record of developing over ten products from IND to NDA/BLA, ultimately launching these for patients in Japan and Asia.

Management

BT Slingsby, MD, PhD, MPH

Chief Executive Officer & Co-Founder

Takeshi Takahashi, MBA

Chief Operating Officer & Co-Founder

Ryutaro Shimazaki

Chief Development Officer

Shin Yamaoka

Chief Commercial Officer

Yoshiro Banno, MPH

Chief Financial Officer

Yoshihide Nakamura

Head of Clinical Study Operations

Jogen Atone

Business Lead

Yayoi Sakuma

Finance & Administration Lead

BOARD OF DIRECTORS

BT Slingsby, MD, PhD, MPH

Executive Chairman & Board Member

Takeshi Takahashi, MBA

Board Member

Nobuo Hanai, PhD

Board Member

Rami Suzuki

Auditor

Investors